Works matching IS 02704137 AND DT 2019 AND VI 79 AND IP 10
Results: 15
IL‐8 protects prostate cancer cells from GSK‐3β‐induced oxidative stress by activating the mTOR signaling pathway.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1180, doi. 10.1002/pros.23836
- By:
- Publication type:
- Article
Targeting prostate cancer cells with enzalutamide‐HDAC inhibitor hybrid drug 2‐75.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1166, doi. 10.1002/pros.23832
- By:
- Publication type:
- Article
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG‐rearranged prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1156, doi. 10.1002/pros.23830
- By:
- Publication type:
- Article
Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1147, doi. 10.1002/pros.23828
- By:
- Publication type:
- Article
Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1133, doi. 10.1002/pros.23826
- By:
- Publication type:
- Article
Potential effect of anti‐inflammatory drug use on PSA kinetics and subsequent prostate cancer diagnosis: Risk stratification in black and white men with benign prostate biopsy.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1090, doi. 10.1002/pros.23820
- By:
- Publication type:
- Article
Association among plasma 1,25(OH)<sub>2</sub>D, ratio of 1,25(OH)<sub>2</sub>D to 25(OH)D, and prostate cancer aggressiveness.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1117, doi. 10.1002/pros.23824
- By:
- Publication type:
- Article
TMPRSS2‐ERG fusions linked to prostate cancer racial health disparities: A focus on Africa.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1191, doi. 10.1002/pros.23823
- By:
- Publication type:
- Article
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1079, doi. 10.1002/pros.23817
- By:
- Publication type:
- Article
Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1099, doi. 10.1002/pros.23821
- By:
- Publication type:
- Article
The association of let‐7c, miR‐21, miR‐145, miR‐182, and miR‐221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low‐risk disease.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1125, doi. 10.1002/pros.23825
- By:
- Publication type:
- Article
An IL‐2 proaerolysin fusion toxin that selectively eliminates regulatory t cells to enhance antitumor immune response.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1071, doi. 10.1002/pros.23819
- By:
- Publication type:
- Article
The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1065, doi. 10.1002/pros.23818
- By:
- Publication type:
- Article
Patterns of response and progression in bone and soft tissue during and after treatment with radium‐223 for metastatic castrate‐resistant prostate cancer.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1106, doi. 10.1002/pros.23822
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Prostate, 2019, v. 79, n. 10, p. 1063, doi. 10.1002/pros.23677
- Publication type:
- Article